Cabecera

Call Type: JOB OFFERS

Call Info

24-126_SS_DL PHD Oncology field (endometrial cancer).

Application Submission process

From: 14/10/2024 00:00 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris

To: 15/12/2024 23:59 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris

Info:

 

PHD Oncology field (endometrial cancer).

REF: 24-126_SS_DL

 

IDIBELL is looking for a motivated candidate to apply for a PFIS predoctoral fellowship (next call in Feb/Mar-2025) to conduct a PhD thesis in the gynecologic oncology field (endometrial cancer)

 

About the research group

Are you interested in biomedical research? We are always looking for talented students to work on elucidating mechanisms of cancer progression and advancing personalized treatments. In particular, we are a young and vibrant team actively focused on the investigation of gynecological tumors. The Gynecologic Cancer group at IDIBELL is actively focused on the identification of genes (coding and non-coding) that are essential for the development and progression of gynecological malignancies (mainly, but not exclusively, endometrial cancer) to ultimately discover novel therapeutic avenues to implement precision medicine in this field. In order to achieve this our group is engaged in multiple projects covering an array of techniques at both in vitro and in vivo level (CRISPR whole genome screenings, RNA_sequencing, proteomics, metabolomics, patient-derived orthoxenografts, etc) and focusing on several key major cellular processes such as autophagy. For more information, please visit www.llobetnavaslab.org.

 

About the role

Future candidates will present a detailed CV that should include, among others, the following items: names of potential references, bachelor marks, previous laboratory experience, publications, participation in seminars and congresses, etc (a list of potential items is detailed below in the "Job Requirements" section). The successful candidate will embark on a project related to womb cancer, immunooncology, therapy resistance and autophagy. The candidate will use a set of in vitro/in vivo models to study: (1) the contribution of HOX family of transcription factors to the development of endometrial cancer, (2) the role of autophagy during endometrial tumorigenesis and (3) the development of novel chemical compounds aimed at targeting the autophagy machinery for therapeutic purposes. We also expect the candidate to engage the project semi-autonomously and to participate in other side-projects carried out in the laboratory.

 

Job requirements

Professional experience

  • Non required

Education and training

  •  Master in cancer-related subjects 

Technical & soft skills

  • Any laboratory experience at molecular, cellular and physiological level with be enthusiastically considered

Languages

  • Good command of the English language

 

We will value, but not required

  • We will positively value the participation of the candidate in research publications
  • Participation in national/international congresses: oral communications or posters
  • Participation in research projects
  • International experience (e.g., erasmus, short-stays, etc)
  • Obtainment of prizes, awards and honors
  • Acquirement of student fellowships/scholarships
  • Participation in dissemination activities, organization of events, small congresses or seminars will be specially valued
  • Acquisition of advanced training certificates
  • Obtainment of animal experimentation license
  • Good adequacy to our group research interests such as previous experience in autophagy/cancer-related work, advanced training courses (e.g., methods of data analysis and statistics, animal experimentation license, etc),

participation in scientific programs, etc

What do we offer

  • No. of positions: 1
  • Contract duration: 4 years
  • Estimated annual gross salary: 20.600 € for the firt and second year, 21.800 € for the third and 26.900 € for the last year.
  • You will be part of a multicultural team. We have a fun loving and friendly international work environment.
  • Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
  • 26 working days of holiday per year
  • System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
  • Paid leave package
  • Benefits of constant training are offered
  • We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Deadline: Please submit your application by  15/12/2024

 

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

 

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

 

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).

 

   

Documentation

Call Document